Lorien Psychiatry
Article
Lorien Psychiatry is a recurring organization in the Astral Codex Ten archive, appearing 5 times across 5 issues between April 28, 2021 and October 25, 2022. The archive places it in contexts such as “I wrote up a short page about Zembrin on my professional website, Lorien Psychiatry”; “database of mental health resources on my other website, Lorien Psychiatry”; “I’m trying to build up a database of mental health resources on my other website, Lorien Psychiatry”. It most often appears alongside CBT, FDA, Scott.
Metadata
- Category: Organizations
- Mention count: 5
- Issue count: 5
- First seen: April 28, 2021
- Last seen: October 25, 2022
Appears In
- Nootropics Survey 2020 Results
- Peer Review Request: Depression
- Peer Review Request: Ketamine
- Peer Review: Nightmares
- From The Mailbag
Related Pages
-
- CBT (2 shared issues)
-
- FDA (2 shared issues)
-
- Scott (2 shared issues)
-
- Substack (2 shared issues)
-
- Zembrin (2 shared issues)
-
- 2002 meta-analysis by Cochrane Collaboration (1 shared issues)
-
- 2020 SSC nootropics survey (1 shared issues)
-
- 5-HTP (1 shared issues)
-
- 5-HTP (1 shared issues)
-
- 80,000 Hours (1 shared issues)
-
- 852 (1 shared issues)
-
- ACX Grants (1 shared issues)
External Links
Source Context
Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.
Based on these preliminary results, I wrote up a short page about Zembrin on my professional website, Lorien Psychiatry, and I asked anyone who planned to try it to preregister with me so I could ask them how it worked later. 29 people preregistered, of whom I was able to follow up with and get data from 22 after a few months. Of those 22, 16 (73%) said it seemed to help, 3 (14%) said it didn't help, and another 3 (14%) couldn't tell because they had to stop taking it due to side effects (two headaches, one case of "psychedelic closed-eye visuals"). Only 13 of the 22 people were willing to give it a score from 1-10 (people hate giving 1-10 scores!), and those averaged 5.9 (6.3 if we don't count people who stopped it immediately due to side effects). That's a little lower than on the survey, but this was a different population - for example, many of them in their answers specifically compared it to prescription antidepressants they'd taken, whereas the survey-takers were comparing it to nootropics. Although these findings are not very useful without a placebo control, they confirm that most people who take Zembrin at least subjectively find it helpful.
Inline links: a short page about Zembrin
I'm trying to build up a database of mental health resources on my other website, Lorien Psychiatry. Every time I post something, people here have made good comments, so I want to try using you all as peer review.
Inline links: Lorien Psychiatry
I'm trying to build up a database of mental health resources on my other website, Lorien Psychiatry. Whenever I post something here, people have had good comments, so I want to try using you all as peer review.
Inline links: Lorien Psychiatry
I'm trying to build up a database of mental health resources on my other website, Lorien Psychiatry. Every time I post something, people here have made good comments, so I want to try using you all as peer review.
Inline links: Lorien Psychiatry
DEAR SCOTT: How is your Lorien Psychiatry business going? — Letitia from Lutetia